ACE2 at the centre of COVID-19 from paucisymptomatic infections to severe pneumonia

Autoimmun Rev. 2020 Jun;19(6):102536. doi: 10.1016/j.autrev.2020.102536. Epub 2020 Apr 3.
No abstract available

Publication types

  • Letter

MeSH terms

  • Air Pollution / statistics & numerical data
  • Alveolar Epithelial Cells / metabolism
  • Alveolar Epithelial Cells / pathology
  • Alveolar Epithelial Cells / virology
  • Angiotensin-Converting Enzyme 2
  • Betacoronavirus / metabolism
  • Betacoronavirus / pathogenicity*
  • COVID-19
  • Coronavirus Infections / epidemiology
  • Coronavirus Infections / immunology
  • Coronavirus Infections / pathology*
  • Coronavirus Infections / virology*
  • Down-Regulation* / drug effects
  • Humans
  • Lung Injury / pathology
  • Lung Injury / virology
  • Lymphohistiocytosis, Hemophagocytic / pathology
  • Lymphohistiocytosis, Hemophagocytic / virology
  • Macrophages / immunology
  • Models, Biological
  • Pandemics
  • Peptidyl-Dipeptidase A / deficiency
  • Peptidyl-Dipeptidase A / metabolism*
  • Pneumonia, Viral / epidemiology
  • Pneumonia, Viral / immunology
  • Pneumonia, Viral / pathology*
  • Pneumonia, Viral / virology
  • Receptors, Virus / deficiency
  • Receptors, Virus / metabolism
  • Respiratory Distress Syndrome / epidemiology
  • Respiratory Distress Syndrome / immunology
  • Respiratory Distress Syndrome / pathology*
  • Respiratory Distress Syndrome / virology
  • SARS-CoV-2
  • Stem Cells / pathology
  • Stem Cells / virology
  • Viral Load
  • Virus Replication

Substances

  • Receptors, Virus
  • Peptidyl-Dipeptidase A
  • ACE2 protein, human
  • Angiotensin-Converting Enzyme 2